Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Title:||Molecular defects of erythroid 5-aminolevulinate synthase in X-linked sideroblastic anemia|
|Citation:||Journal of Bioenergetics and Biomembranes, 1995; 27(2):161-168|
|Publisher:||Plenum Publishing Corporation|
|Bottomley, Sylvia; May, Brian; Cox, Timothy; Cotter, Philip; Bishop, David|
|Abstract:||The erythroid-specific isozyme of 5-aminolevulinate synthase (ALAS2), the first and ratelimiting enzyme of heme biosynthesis, is expressed concomitantly with the differentiation and maturation of the erythroid cell in order to accommodate generation of the large amounts of heme required for hemoglobin production. During the past few years the ALAS2 gene and its transcript have been characterized and the amino acid sequence of the enzyme deduced. The human genetic disorder X-linked sideroblastic anemia, previously postulated to be caused by defects of ALAS, has now been analyzed at the molecular and tissue-specific level. A heterogeneous group of point mutations in the catalytic domain of the ALAS2 enzyme has been found to cause the disorder. Impaired activity of recombinant mutant ALAS2 enzymes has also been demonstrated. Characterization of molecular defects in individuals with X-linked sideroblastic anemia has provided improved diagnosis for at-risk family members.|
|Appears in Collections:||Biochemistry publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.